Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Ash

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Applied Microbiology|July 1, 1974
Influence of viral envelope on Newcastle disease virus infectionN P Young, R J Ash
Journal of Clinical Microbiology|September 1, 1975
Optimal cooling and warming rates in the preservation of herpes simplex virus (type 2)R J Ash, E R Barnhart
Applied Microbiology|December 1, 1972
Growth characteristics of a herpesvirus of turkeysR J Ash, J D Ware
Journal of the National Cancer Institute|December 1, 1975
Metabolic characteristics of cells infected with a herpesvirus of turkeysJ D Ware, W J Bellini, R J Ash
The Journal of Infectious Diseases|May 1, 1978
Salivary neutralizing activity against herpes simplex virus type 1R Gyselink, D Coles, R J Ash, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1984
Importance of the hydrophobic sulfoxide substituent on nontoxic analogs of sparsomycinR J Ash, L D Fite, D W Beight, et al.
Biochemical and Biophysical Research Communications|December 14, 1984
Sulfoxide configuration in sparsomycin determines time-dependent and competitive inhibition of peptidyl transferaseR J Ash, G A Flynn, R M Liskamp, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
RMI 15,731 (1-[5-tetradecyloxy-2-furanyl]-ethanone), a new antirhinovirus compoundR J Ash, R A Parker, A C Hagan, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Applied Microbiology|July 1, 1974
Influence of viral envelope on Newcastle disease virus infectionN P Young, R J Ash
Journal of Clinical Microbiology|September 1, 1975
Optimal cooling and warming rates in the preservation of herpes simplex virus (type 2)R J Ash, E R Barnhart
Applied Microbiology|December 1, 1972
Growth characteristics of a herpesvirus of turkeysR J Ash, J D Ware
Journal of the National Cancer Institute|December 1, 1975
Metabolic characteristics of cells infected with a herpesvirus of turkeysJ D Ware, W J Bellini, R J Ash
The Journal of Infectious Diseases|May 1, 1978
Salivary neutralizing activity against herpes simplex virus type 1R Gyselink, D Coles, R J Ash, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1984
Importance of the hydrophobic sulfoxide substituent on nontoxic analogs of sparsomycinR J Ash, L D Fite, D W Beight, et al.
Biochemical and Biophysical Research Communications|December 14, 1984
Sulfoxide configuration in sparsomycin determines time-dependent and competitive inhibition of peptidyl transferaseR J Ash, G A Flynn, R M Liskamp, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
RMI 15,731 (1-[5-tetradecyloxy-2-furanyl]-ethanone), a new antirhinovirus compoundR J Ash, R A Parker, A C Hagan, et al.
Pageof 2